January 31, 2023
April Tabor
Secretary Federal Trade Commission
600 Pennsylvania Avenue NW
Suite CC-5610 (Annex C)
Washington, DC 20580
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform
AHA comments proposed revisions to the regulations governing the confidentiality of substance use disorder (SUD) records, commonly known as 42 CFR Part 2 (“Part 2”).
January 27, 2023
AHA Comments on AHRQ’s Request for Information on Creating a National Health Care System Action Alliance to Advance Patient Safety, Dec. 12, 2022
The AHA appreciates the opportunity to share our comments and asks that commissioners consider the following issues before making their final payment update recommendations.
AHA expresses concern about the potential impact of H.R. 3648, the Equal
Access to Green Cards for Legal Employment (EAGLE) Act of 2022